EZSolution™ Triacsin C for cell activation

EZSolution(TM) Triacsicn C, is an Inhibitor of acyl-CoA synthetase (IC₅₀ = 6.3 μM in Raji cells). Inhibits lipid synthesis and cell proliferation in Raji lymphoma cells. Induces apoptosis in cancer cell lines and inhibits human lung cancer cell xenograft tumor growth in mice. It has been shown to interfere with lipid metabolism by inhibiting the de novo synthesis of triglycerides, diglycerides, and cholesterol esters.

N/A

76896-80-5

207.27

Biochemicals

(2E,4E,7E)-2,4,7-Undecatrienal nitrosohydrazone

C₁₁H₁₇N₃O

Liquid

In DMSO (1 mg/ml)

No

Yes

≥90% by TLC

N/A

-20°C

gel pack

36 months

Protect from air and moisture

cell

For cells, cell lines and tissues in culture till half confluency.